The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor reactive T cells from the cerebrospinal fluid of patients with leptomeningeal disease from melanoma.
 
Yolanda Pina
Research Funding - Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation (Inst)
 
Michael Carter
No Relationships to Disclose
 
Maclean Hall
Stock and Other Ownership Interests - Abbvie; Amgen; Biohaven Pharmaceuticals; Bristol Myers Squibb; CVS Health; Elevance Health; Microsoft; Omega Healthcare Investors; SABRA Health REIT; UnitedHealthcare
Research Funding - Iovance Biotherapeutics; Turnstone Bio
Patents, Royalties, Other Intellectual Property - Moffitt Cancer Center has licensed Intellectual Property related to the proliferation and expansion of tumor-infiltrating lymphocytes (TIL) to Iovance Biotherapeutics. I am a co-inventor on such Intellectual Property.
 
Madeline Rodriguez Valentin
No Relationships to Disclose
 
Matt Beatty
Consulting or Advisory Role - Tuhura Biosciences
Research Funding - Turnstone Bio (Inst)
 
Peter A. J. Forsyth
Honoraria - Abbvie; BTG; Novocure; Stanford University Health, Department of Neurology
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; BTG; Midatech Pharma; National Brain Tumor Society; Novartis; Novocure; Tocagen; ZIOPHARM Oncology
Research Funding - Bankhead-Coley Cancer Research; Bristol-Myers Squibb; Department of Defense; Florida Academic Cancer Center Alliance; Florida Breast Cancer Foundation; MSCCoE; NIH/NCI; Pfizer
Travel, Accommodations, Expenses - Abbvie; Bayer; Bristol-Myers Squibb; BTG; Inovio Pharmaceuticals; National Cancer Research Institute (NCRI); NCCN; NCI; NIH; Physical Sciences Oncology Network
 
Shari Pilon-Thomas
Consulting or Advisory Role - KSQ Therapeutics; Morphogenesis, Inc.
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Dyve Biosciences (Inst); Intellia Therapeutics (Inst); Iovance Biotherapeutics (Inst); Provectus (Inst); Turnstone Bio (Inst)
Patents, Royalties, Other Intellectual Property - IP licensed from Moffitt to Tuhura. (Inst); Moffitt Cancer Center has licensed Intellectual Property related to the proliferation and expansion of tumor infiltrating lymphocytes (TILs) to Iovance Biotherapeutics. Shari Pilon-Thomas is an inventor on such Intellectual Property. (Inst); Patent with Provectus (Inst)